News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Merus N.V.
Merus Announces First Patient Dosed in Phase 2 Trial of Petosemtamab in 2L CRC
July 08, 2024
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus Appoints Fabian Zohren M.D., Ph.D., as Chief Medical Officer
July 01, 2024
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus’ MCLA-129 Demonstrates Promising Single-Agent Efficiency in METex14 NSCLC in Poster Presentation at the 2024 ASCO® Annual Meeting
June 03, 2024
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 2024 ASCO® Annual Meeting
June 02, 2024
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus Announces Pricing of Upsized Public Offering of Common Shares
May 29, 2024
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
May 29, 2024
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus N.V. Announces Proposed Public Offering of Common Shares
May 28, 2024
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus’ Petosemtamab in Combination with Pembrolizumab Interim Data Demonstrates Robust Response Rate and Favorable Safety Profile in 1L r/m HNSCC
May 28, 2024
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus Announces Publication of Abstracts for Presentation at the 2024 ASCO® Annual Meeting
May 23, 2024
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m HNSCC at the 2024 ASCO® Annual Meeting
May 23, 2024
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Petosemtamab granted Breakthrough Therapy Designation by the U.S. FDA
May 13, 2024
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
May 08, 2024
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus Announces U.S. FDA Acceptance and Priority Review of Biologics License Application for Zeno for the Treatment of NRG1+ NSCLC and PDAC
May 06, 2024
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
April 24, 2024
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus Presents Preclinical Data Demonstrating Efficacy of Zeno in Cancer Models with High NRG1 Expression at the AACR Annual Meeting 2024
April 08, 2024
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus to Participate in a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
April 03, 2024
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus Announces Publication of an Abstract for Presentation at the AACR Annual Meeting 2024: Zeno is effective in cancer models with high NRG1 expression
March 05, 2024
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus to Participate in a Fireside Chat at the Leerink Partners Global Biopharma Conference
March 04, 2024
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Update
February 28, 2024
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus to Participate in Upcoming Investor Conferences
January 31, 2024
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus Presents Interim Data on MCLA-129 at ESMO Asia Congress 2023
December 02, 2023
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus Announces Publication of Abstracts on MCLA-129 for Presentation at ESMO Asia Congress 2023
November 26, 2023
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update
November 02, 2023
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus to Participate in Upcoming Investor Conferences
November 01, 2023
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus’ Zeno Interim Data Continues to Demonstrate Robust and Durable Responses in NRG1+ Cancer
October 23, 2023
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus Announces Business Update Conference Call
October 15, 2023
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus Announces Abstracts Accepted for Presentation at the ESMO Asia Congress 2023
October 06, 2023
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus to Participate in Upcoming Investor Conferences
August 31, 2023
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus Announces Pricing of Public Offering of Common Shares
August 09, 2023
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Merus N.V. Announces Proposed Public Offering of Common Shares
August 09, 2023
From
Merus N.V.
Via
GlobeNewswire
Tickers
MRUS
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.